Securian Asset Management Inc. Sells 1,095 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Securian Asset Management Inc. lessened its position in Henry Schein, Inc. (NASDAQ:HSIC) by 11.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,228 shares of the company’s stock after selling 1,095 shares during the quarter. Securian Asset Management Inc.’s holdings in Henry Schein were worth $623,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. McGlone Suttner Wealth Management Inc. acquired a new stake in Henry Schein in the 4th quarter worth $39,000. Neo Ivy Capital Management acquired a new stake in Henry Schein in the 3rd quarter worth $46,000. Covestor Ltd grew its position in Henry Schein by 22.8% in the 3rd quarter. Covestor Ltd now owns 1,367 shares of the company’s stock worth $102,000 after purchasing an additional 254 shares during the last quarter. Benjamin F. Edwards & Company Inc. grew its position in Henry Schein by 37.8% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock worth $114,000 after purchasing an additional 416 shares during the last quarter. Finally, GAMMA Investing LLC acquired a new stake in Henry Schein in the 4th quarter worth $115,000. Institutional investors own 96.62% of the company’s stock.

Henry Schein Trading Down 1.2 %

Shares of HSIC stock opened at $72.38 on Thursday. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63. The company has a market capitalization of $9.27 billion, a P/E ratio of 24.45, a P/E/G ratio of 1.84 and a beta of 0.87. The firm has a 50-day moving average price of $72.61 and a 200 day moving average price of $72.91. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.21 billion. During the same period in the previous year, the firm posted $1.21 earnings per share. The company’s revenue was up 3.7% on a year-over-year basis. Research analysts forecast that Henry Schein, Inc. will post 5.08 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on HSIC. Evercore ISI raised their price target on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research report on Wednesday, February 28th. UBS Group decreased their target price on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. SVB Leerink assumed coverage on shares of Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 target price on the stock. Jefferies Financial Group lifted their target price on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research report on Wednesday, March 6th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research report on Wednesday, March 6th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Henry Schein currently has a consensus rating of “Hold” and an average target price of $81.73.

Insiders Place Their Bets

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.